GM Grass Unregulated

New technology evades the USDA’s authority to control genetically-modified plants.

Written byJessica P. Johnson
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

Kentucky bluegrassWIKIMEDIA COMMONS, FABELFROH

A new technology used to create a genetically modified (GM) version of Kentucky bluegrass prompted the USDA to announce on July 1 that it has no authority over the plant’s regulation, reports Nature.

Rules currently in place that give the US Department of Agriculture regulatory authority over GM plants are based on the Federal Plant Pest Act, passed in 1957, which was actually designed to protect agricultural crops from foreign disease infestations. But the Act was adopted for GM plant regulation because the techniques used in their modification involve the use of viruses and tumor-causing bacteria, such as the bacterium Agrobacterium tumefaciens, which transports genes that confer disease resistance into plant genomes. Genetic elements derived from plant viruses are then used to turn these genes ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies